• Skip to primary navigation
  • Skip to main content

Stanford Alliance for Primary Immunodeficiency

Stanford University

  • SAPI
  • Stanford PI Clinic
  • Patient Support
    • Diagnosis
    • Treatment and Complications
    • School
    • Work
    • Parenting
    • Sibling
    • Lifestyle
    • Mentorship Program
    • PI Resources
      • Immune Deficiency Foundation (IDF)
      • Jeffrey Modell Foundation
      • Painted Turtle Camp
      • Make-A-Wish
      • Baxter IVIG
      • CSL Behring IVIG
  • Kids’ Zone
    • Kids’ Zone
    • Pre-Teen FAQ
    • Teen FAQ
  • PID Research
    • Butte Lab Immunology Research Projects
    • PID Research blog
  • Local Events
  • Donate
You are here: Home / Archives for Research

Research

Primary sclerosing cholangitis in common variable immune deficiency.

January 12, 2016 By Manish Butte

Related Articles

Primary sclerosing cholangitis in common variable immune deficiency.

Allergol Int. 2015 Apr;64(2):187-9

Authors: Mahdavinia M, Mirsaeidi M, Bishehsari F, McGrath K

PMID: 25838096 [PubMed – indexed for MEDLINE]

Powered by WPeMatico

Filed Under: Research

Helicobacter pylori infection in patients with selective immunoglobulin A deficiency.

January 11, 2016 By Manish Butte

Helicobacter pylori infection in patients with selective immunoglobulin A deficiency.

Clin Exp Immunol. 2016 Jan 8;

Authors: Magen E, Waitman DA, Goldstein N, Schlesinger M, Dickstein Y, Kahan NR

Abstract
BACKGROUND: Selective IgA deficiency (IgAD) is the most common primary immunodeficiency in the Western world. The aim of the study was to investigate the prevalence and clinical characteristics of Helicobacter pylori (H. pylori) infected dyspeptic patients with IgAD.
MATERIALS AND METHODS: Case samples were drawn from all subjects ≥ 12 years of age (n = 104729), who that had undergone serum total IgA measurements during 2004 – 2014 years for any reason at Leumit Healthcare Services (Israel) and had serum total IgA <0.07 g/L. The control group was comprised of a random sample of remaining patients with a case-control ratio ten controls for each case. The dyspeptic diseases were identified and retrieved from Leumit Health Care Services electronic database using specific ICD-9-CM diagnostic codes.
RESULTS: Case group included 347 subjects and Control group 3470 subjects. There were no significant difference in the prevalence of patients with dyspepsia (84 (24.2%) vs 821 (23.6%) for cases and controls, respectively). Additionally, there was no difference in a proportion of dyspeptic H. pylori-positive subjects (59 (17.1%) vs 524 (15.1%) between the case and control groups.Only 59 (17%) among the 347 IgAD patients underwent gastroscopy. Crude numbers of all the patients with experienced gastritis. A significantly larger proportion of case subjects experienced several forms gastritis (13 (61.9%) vs.38 (21.6%), p<0.001), duodenal ulcers (7 (33.3%) vs 19 (10.8%); p = 0.01) and nodular lymphoid hyperplasia (NLH) (2 (9.5%) vs 0; p=0.011).
CONCLUSIONS: IgAD is not associated with increased prevalence of H. pylori associated dyspepsia, nevertheless H.pylori infected dyspeptic IgAD subjects experience more EGD proved gastritis, duodenal ulcers and NLH. This article is protected by copyright. All rights reserved.

PMID: 26749258 [PubMed – as supplied by publisher]

Powered by WPeMatico

Filed Under: Research

Clinical and structural impact of mutations affecting the residue Phe367 of FOXP3 in patients with IPEX syndrome.

January 10, 2016 By Manish Butte

Clinical and structural impact of mutations affecting the residue Phe367 of FOXP3 in patients with IPEX syndrome.

Clin Immunol. 2015 Dec 31;

Authors: Colobran R, de la Campa EÁ, Soler-Palacín P, Martín-Nalda A, Pujol-Borrell R, de la Cruz X, Martínez-Gallo M

Abstract
Immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome is a monogenic autoimmune disease characterized by early-onset life-threatening multisystemic autoimmunity. This rare hereditary disorder is caused by loss-of-function mutations in the gene encoding the forkhead box P3 (FOXP3) transcription factor, which plays a key role in the differentiation and function of CD4(+)CD25(+) natural regulatory T cells (Tregs), essential for the establishment and maintenance of natural tolerance. We identified a novel mutation in the FOXP3 gene affecting the Phe367 residue of the protein (F367V) in a family with three male siblings affected by IPEX. Two other mutations affecting the FOXP3 Phe367 residue (F367L and F367C) have been described previously. This unique situation of three mutations affecting the same residue in FOXP3 led us to study the molecular impact of these mutations on the structure of FOXP3 protein. Structure analysis showed that Phe367 is involved in a rich interaction network related to both monomer and dimer structure stabilization, and is crucial for FOXP3 regulatory activity. The relevance of this location is confirmed by the results of SIFT and PolyPhen-2 pathogenicity predictions for F367V mutation. In summary, as assessment of the pathogenicity of a novel mutation is crucial to achieve a proper molecular diagnosis, we analysed the impact of mutations affecting the Phe367 residue using a combined approach that provides a mechanistic view of their pathogenic effect.

PMID: 26748374 [PubMed – as supplied by publisher]

Powered by WPeMatico

Filed Under: Research

Advances in Understanding the Pathogenesis of Epstein-Barr Virus-Associated Lymphoproliferative Disorders.

January 9, 2016 By Manish Butte

Related Articles

Advances in Understanding the Pathogenesis of Epstein-Barr Virus-Associated Lymphoproliferative Disorders.

Iran J Allergy Asthma Immunol. 2015 Oct;14(5):462-71

Authors: Yang X, Nishida N, Zhao X, Kanegane H

Abstract
Epstein-Barr virus (EBV) was discovered 50 years ago  from an african Burkitt lymphoma cell line. EBV-associated lymphoproliferative disorders (LPDs) are life- threatening diseases, especially in children. In this article, we review EBV-associated LPDs, especially in the area of primary immunodeficiency disease (PID). We searched PubMed for publications with key words including EBV infection, lymphoma, LPDs and PID, and selected the manuscripts written in English that we judged to be relevant to the topic of this review.On the basis of the data in the literature, we grouped the EBV-associated LPDs into four categories: nonmalignant disease, malignant disease, acquired immunodeficiency disease and PID. Each category has its own risk factor for LPD development. EBV-associated LPD is a complex disease, creating new challenges for diagnosis and treatment.

PMID: 26742434 [PubMed – in process]

Powered by WPeMatico

Filed Under: Research

Common variable immunodeficiency diagnosed during the treatment of bronchial asthma: Unusual cause of wheezing.

January 9, 2016 By Manish Butte

Related Articles

Common variable immunodeficiency diagnosed during the treatment of bronchial asthma: Unusual cause of wheezing.

Respir Med Case Rep. 2015;16:41-4

Authors: Akaba T, Kondo M, Toriyama M, Kubo A, Hara K, Yamada T, Yoshinaga K, Tamaoki J

Abstract
Common variable immunodeficiency (CVID) is the most frequent primary immunodeficiency in adults and children. We herein report a case of CVID, who was misdiagnosed with asthma due to wheezing episodes and relatively late onset. A 51-year-old woman had suffered from recurrent upper and lower airway infection for recent 2 years. She repeated wheezing attacks and was treated as asthma exacerbation triggered by infection. She was referred to our hospital for investigation and treatment. Lung function tests showed no reversibility of FEV1 by β-adrenergic agonist, but the increase of V50/V25. Chest CT showed slight to moderate bronchial wall thickening and bronchiectasis. After that, she suffered from pneumonia with wheezing attacks twice a month, and immunodeficiency was strongly suspected. Her blood tests showed marked decreases of all classes of immunoglobulin and nearly lack of memory B cells, NKT cells and plasmacytoid dendritic cells. She was diagnosed with CVID, and was treated with replacement of gammaglobulin. Thereafter, her wheezing episodes with infection were remarkably improved. Because the delay of diagnosis with CVID likely causes poor mortality and morbidity, a possibility of CVID should be considered in patients with frequent asthma-like symptoms due to recurrent airway infection.

PMID: 26744651 [PubMed]

Powered by WPeMatico

Filed Under: Research

A case of APDS patient: defects in maturation and function and decreased in vitro anti-mycobacterial activity in the myeloid compartment.

January 7, 2016 By Manish Butte

A case of APDS patient: defects in maturation and function and decreased in vitro anti-mycobacterial activity in the myeloid compartment.

Clin Immunol. 2015 Dec 27;

Authors: Chiriaco M, Brigida I, Ariganello P, Di Cesare S, Di Matteo G, Taus F, Cittaro D, Lazarevic D, Scarselli A, Santilli V, Attardi E, Stupka E, Giannelli S, Fraziano M, Finocchi A, Rossi P, Aiuti A, Palma P, Cancrini C

Abstract
Activated PI3-Kinase Delta Syndrome (APDS) was recently reported as a novel Primary Immunodeficiency caused by heterozygous gain-of-function mutations in PIK3CD gene. Here we describe immunological studies in a 19 years old APDS patient for whom genetic diagnosis was discovered by Whole Exome Sequencing (WES) analysis. In addition to the progressive lymphopenia and defective antibody production we showed that the ability of patient’s B cells to differentiate in vitro is severely reduced. An in depth analysis of the myeloid compartment showed an increased expression of CD83 activation marker on monocytes and mono-derived DC cells. Moreover, monocytes-derived macrophages (MDM) failed to solve Mycobacterium bovis bacillus Calmette Guèrin (BCG) infection in vitro. Selective p110δ inhibitor IC87114 restored the MDM capacity to kill BCG in vitro. Our data show that the constitutive activation of Akt-mTOR pathway induces important alterations also in the myeloid compartment providing new insights in order to improve therapeutic approach in these patients.

PMID: 26732860 [PubMed – as supplied by publisher]

Powered by WPeMatico

Filed Under: Research

Parental Views on Expanded Newborn Screening Using Whole-Genome Sequencing.

January 6, 2016 By Manish Butte

Related Articles

Parental Views on Expanded Newborn Screening Using Whole-Genome Sequencing.

Pediatrics. 2016 Jan;137 Suppl 1:S36-46

Authors: Joseph G, Chen F, Harris-Wai J, Puck JM, Young C, Koenig BA

Abstract
BACKGROUND AND OBJECTIVE: The potential application of whole-genome sequencing (WGS) to state-mandated standard newborn screening (NBS) challenges the traditional public health approach to NBS and raises ethical, policy, and clinical practice issues. This article examines the perspectives and values of diverse healthy pregnant women and parents of children diagnosed with a primary immunodeficiency disorder about traditional NBS and expanded NBS with the use of WGS.
METHODS: We conducted 4 focus groups (3 in English and 1 in Spanish) with socioeconomically and ethnically diverse pregnant women (n = 26), and a comparison group with parents of children diagnosed with a primary immunodeficiency disorder (n = 5).
RESULTS: Pediatric policy-relevant themes that emerged from our analysis of the focus group data are presented within 4 categories: (1) perspectives on traditional NBS, (2) informed consent, (3) return of results, and (4) storage and retrieval of results. Analyses indicate that study participants desired greater inclusion in the NBS process. Despite an optimistic orientation to the potential benefits and limited harms likely to result from genomic applications of NBS, parents voiced concerns about privacy and control over test results. Limited trust in the medical system and the state-run NBS program informed these concerns.
CONCLUSIONS: Expanded NBS with WGS for pediatricians may require management of more genetic conditions, including mutations that convey risk to both the child and parents for adult-onset disorders, and an informed-consent process to manage the genomic data and storage of blood spots. Attention to how these technologies are understood in diverse populations is needed for effective implementation.

PMID: 26729702 [PubMed – in process]

Powered by WPeMatico

Filed Under: Research

[Merkel cell carcinoma in patient after organ transplantation].

January 6, 2016 By Manish Butte

Related Articles

[Merkel cell carcinoma in patient after organ transplantation].

Przegl Lek. 2015;72(2):83-6

Authors: Sułowicz J, Wojas-Pelc A, Sułowicz W

Abstract
Merkel cell carcinoma (MCC) is a rare, neuroendocrine tumour of the skin characterized by a very aggressive course. Firm, red-to-purple, typically non tender papules or nodules is a common of it’s clinical manifestation. This carcinoma is more common among white Caucasians males in advanced age. The important risk factors for MCC are immunodeficiency or immunosuppression in patients after organ transplantation. MCC observed in organ recipients is associated with especially rapid progression as compared with general population and tendency to metastasis. Surgical excision of primary tumour with adequate margins and sentinel lymph node dissection with adjuvant radiotherapy improves regional control of disease and patients survival. Chemotherapy is usually used as a palliative treatment for advanced forms of the disease.

PMID: 26727749 [PubMed – in process]

Powered by WPeMatico

Filed Under: Research

Noninfectious Granulomas: A Sign of an Underlying Immunodeficiency?

January 6, 2016 By Manish Butte

Related Articles

Noninfectious Granulomas: A Sign of an Underlying Immunodeficiency?

J Cutan Med Surg. 2016 Jan 4;

Authors: Shoimer I, Wright N, Haber RM

Abstract
Primary immunodeficiency disorders, such as ataxia-telangiectasia (A-T), may rarely be associated with cutaneous granulomas without an identifiable infection. The authors report a case of a 3-year-old boy with A-T who presented with two persistent ulcerated erythematous nodules. Histopathology was consistent with a granulomatous process secondary to A-T, without an infectious origin. Partial improvement was noted with clobetasol propionate 0.05% cream applied twice daily under occlusion. Of note, the presence of multiple noninfectious granulomas in a child may be the initial sign of an immune deficiency and should alert the astute clinician to investigate for an underlying primary immunodeficiency. Herein, the authors discuss the associations of noninfectious granulomas and primary immunodeficiency disorders and present management options for these difficult-to-treat lesions.

PMID: 26728658 [PubMed – as supplied by publisher]

Powered by WPeMatico

Filed Under: Research

Fatal pulmonary complications in an immunodeficient child with chronic active Epstein-Barr virus infection.

January 5, 2016 By Manish Butte

Related Articles

Fatal pulmonary complications in an immunodeficient child with chronic active Epstein-Barr virus infection.

Pneumonol Alergol Pol. 2014;82(4):364-7

Authors: Szczawińska-Popłonyk A, Jończyk-Potoczna K, Ossowska L, Bręborowicz A

Abstract
Primary Epstein-Barr virus infection in children typically presents as infectious mononucleosis and in immunocompetent individuals severe pneumonitis proves to be a rare complication. Chronic active Epstein-Barr virus infection (CAEBV) is associated with multiple life-threatening conditions, including interstitial lung disease with fibrosis and lymphoid and lymphohistiocytic infiltrations. We report on a pediatric patient in whom CAEBV resulted in severe pneumopathy with a fatal outcome.

PMID: 24964240 [PubMed – indexed for MEDLINE]

Powered by WPeMatico

Filed Under: Research

  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 635
  • Page 636
  • Page 637
  • Page 638
  • Page 639
  • Interim pages omitted …
  • Page 711
  • Go to Next Page »

Copyright © 2026 · Genesis Framework by StudioPress · WordPress · Log in